GeneDx Holdings Corp.: ARK Investment Management LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
ARK Investment Management LLC amended its Schedule 13G filing for GeneDx Holdings Corp., disclosing a change in its beneficial ownership stake in the genetic testing company. The amendment was filed with the SEC under accession number 0001104659-26-126827. ARK's move draws attention to institutional positioning in GeneDx, a volatile small-cap name that has attracted active-manager interest. Investors will watch for further 13G amendments to gauge whether ARK is building or trimming its position.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
ARK Investment Management LLC, GeneDx Holdings Corp.